Journal of Rheumatology

Article	Citations
Is Real-world Evidence Really Real?	72
Drs. Dai and Fan reply	55
50th Year of Publication: Revisiting the 1980s	38
Canadian Rheumatology Association Annual Scientific Meeting; RBC Convention Centre (and Virtually); Winnipeg, Manitoba, Canada; February 28–March 2, 2024	36
Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association With HLA-B27 in European and Ibero-American Populations	35
Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada	30
Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry	29
Remission in Gout: Concepts From a Patient Perspective	28
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?	27
A Move Toward Precision: Innovations in Measuring Spinal Mobility in Axial Spondyloarthritis	27
Dr. Gottlieb et al reply	27
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort	27
“Gallia est omnis divisa in partes tres”: Social Media Platforms as a New Educational Channel for Pediatric Rheumatology	26
Arthritis Mutilans in Jo1 Antisynthetase Syndrome	25
The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis: Real-World Data	24
Aneurysmal Disease in Patients With Takayasu Arteritis	24
A Reciprocal Machine Learning Approach to Defining Physiologic Compensation of the Synovial Joint in Knee Osteoarthritis	24
Is There Relevance of a Positive Rheumatoid Factor in Systemic Sclerosis? A Systematic Review of the Literature	24
Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series	24
The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis	23
Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test	22
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting	22
Follow-up Contrast-Enhanced Ultrasonography of the Carotid Artery in Patients With Takayasu Arteritis: A Retrospective Study	22
Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND	21
Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use	21

DYSREGULATION OF THE EXPRESSION OF HUMAN RETROVIRUSES IN SYSTEMIC LUPUS ERYTHEMATOSUS	20
CD38 IS OVEREXPRESSED BY IMMUNE CELLS IN CUTANEOUS LUPUS SKIN	20
EFFECT OF CENERIMOD, AN S1P1 MODULATOR, ON FATIGUE IN SLE: RESULTS FROM THE PHASE 2 CARE STUDY	20
THE USE OF POLYSIMPTOMATIC DISTRESS SCALE IN A MULTICENTRIC COHORT OF SLE PATIENTS TO IDENTIFY PATIENTS WITH HIGH LEVELS TYPE 2 SYMPTOMS	20
OUTCOMES OF ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS: A SCOPING REVIEW	19
DELAYED ONSET OF MALE INFERTILITY AFTER TREATMENT WITH HIGH DOSE OF CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS	19
AN UNUSUAL CASE OF LYMPHOCYTIC ENTEROCOLITIS AND VASCULITIS AS THE INITIAL MANIFESTATION OF SLE	18
ANTI-Β2GLYCOPROTEIN I-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS CAUSE ENDOTHELIAL ACTIVATION	18
EFAVALEUKIN ALFA IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A BAYESIAN ADAPTIVE, PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DOSE-RANGING STUDY	18
CONTEMPORARY KIDNEY OUTCOMES AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES	18
THE IMPORTANCE OF TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY IN DIAGNOSING LIBMAN-SACKS ENDOCARDITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT	17
PRISTANE-INDUCED LUPUS MICE PRESENT INCREASED MEGAKARYOCYTE COUNTS ALONGSIDE OTHER HISTOPATHOLOGICAL FEATURES IN THE SPLENIC TISSUE	17
Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis	16
TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition	16
The State of Patient-Reported Outcome Measures in Rheumatology	16
Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A	16
How to Identify and Monitor Axial and Peripheral Psoriatic Arthritis by Magnetic Resonance Imaging	15
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease	15
Modifiable Lifestyle Factors, Genetic Susceptibility, and Incident Radiographic Axial Spondyloarthritis	15
Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain	15
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist	15
Risk of Cancer Among Sarcoidosis Patients With Biopsy-verified Nonnecrotizing Granulomatous Inflammation: Population-based Cohort Study	15
Inflammation as a Treatment Target in Hand Osteoarthritis: A Review of Previous Studies and Future Perspectives	15
Challenges of ASAS criteria in Real-World Colombia SpA patients. A cross-sectional study	14
Modulating the Gut-Joint Axis: The Impact of Anti-TNF Therapy on Gut Microbiota in Ankylosing Spondylitis - A Systematic Review	13
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	13
Text-Based Messaging to Support Rheumatoid Arthritis Care: An Analysis of the Frequency and Content of Text Messages	13
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review	13
Current Barriers to Accessing Mental Healthcare Resources for Inflammatory Arthritis Patients and How to Improve Support	13
Atlantoaxial Subluxation in Patients with Psoriatic Arthritis	13
Development of MOGAD in a Patient with Granulomatosis with Polyangiitis and Giant Cell Arteritis Overlap Syndrome	12
How Does Juvenile Idiopathic Arthritis Affect the Employment and Usual Activities of Adolescents? The UCAN CAN-DU and CURE International Prospective Study	12
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculi	12
Long-Term Outcomes in Lung Transplant for Anti-Melanoma Differentiation-Associated Gene 5 Antibody Positive Interstitial Lung Disease: A Case Series	12
The Uses and Advances in Imaging for Psoriatic Arthritis: A Scoping Review	12
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study	12
Exploring Causal Relationships of Depression and Psoriatic Disease (Psoriatic Arthritis and Psoriasis) Through Mendelian Randomization	12
The Efficacy of Leflunomide in the Treatment of Giant Cell Arteritis: A Systematic Review and Meta-Analysis	12
Negative Health Impacts of Navigating the Healthcare System for Musculoskeletal Conditions: Healthcare User Perspectives	12
A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease	12
Scrotal Calcinosis in Juvenile Systemic Sclerosis	11
Drs. Chung and McMahan reply	11
Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus	11
Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients	11
Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases	11
Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan	11
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib	11
The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study	11
Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation	11
Functional Connectivity and Structural Signatures of the Visual Cortical System in Fibromyalgia: A Magnetic Resonance Imaging Study	11

DRUG LEVELS AND ANTI-DRUG ANTIBODIES OVER 2 YEARS OF BELIMUMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS	11
Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis	11
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus	11
Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation	11
Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients	11
A Population-based Study of Grade 12 Academic Performance in Adolescents With Childhood-onset Chronic Rheumatic Diseases	11
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review	11
SIMILARITY AND DIVERSITY IMMUNOLOGICAL ABERRATIONS IN STABLE BENIGN IMMUNITY AND TOWARD ANA-RELATED AUTOIMMUNE DISEASES IN ANA-POSITIVE AT-RISK POPULATIONS	10
VARIATIONS IN TACROLIMUS WHOLE BLOOD CONCENTRATIONS DURING PREGNANCY AND ITS IMPLICATIONS FOR THERAPEUTIC DRUG MONITORING: A SYSTEMATIC REVIEW AND META-ANALYSIS	10
DOES SLEDAI-2K REFLECT THE INTERFERON-ALPHA GENE SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS? PRELIMINARY RESULTS FROM A COHORT	10
IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT	10
CHARACTERISTICS OF NEUROLOGICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS AT A TERTIARY UNIVERSITY HOSPITAL	10
ADMINISTRATION OF BELIMUMAB IN EARLY ACTIVE LUPUS PATIENTS HINDERS ACCRUAL OF EULAR/ACR CRITERIA WITHIN THE FIRST 12 MONTHS OF TREATMENT	10
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus	10
SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INDUCTION TREATMENTS FOR LUPUS NEPHRITIS	10
THE TYPE I IFN SIGNATURE BETWEEN PATIENTS WITH RA AND SLE.	10
VALIDATION OF A SCORE FOR THE PREDICTION OF SERIOUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A LATIN AMERICAN LUPUS COHORT	10
SERUM NEUROFILAMENT LIGHT TO DISTINGUISH AND MONITOR ACTIVITY IN A COHORT OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	10
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS	10
INCREASE OF IL10 AND INFA2 ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS	9
RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A	9
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter Study	9
Unveiling Deficiency of Adenosine Deaminase 2: An Adult Patient With Recurrent Strokes, Vasculitic Ulcers, and Bowel Perforation	9
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies	9
ASSOCIATION BETWEEN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE OUTCOMES AND DISEASE ACTIVITY IN SLE: A REAL-WORLD COHORT STUDY	9
GENETICS OF EGFR VARIABILITY AS A PROXY FOR LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	9
FACTORS INFLUENCING SUBJECTIVE MENTAL ALTERATIONS: UNRAVELING THE LUPUS BRAIN FOG	9
Formulating Knee Osteoarthritis Management Plans Taking Type 2 Diabetes Into Account: Qualitative Study of Arthritis Therapists Using Theoretical Domains Framework	9
High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance?	9
ASSESSMENT OF FATIGUE IN A MONOCENTRIC ITALIAN COHORT OF PATIENTS AFFECTED BY SLE AND OTHER RHEUMATIC DISEASES (RDS) THROUGH VALIDATED QUESTIONNAIRES	9
ALL SUBCOMPONENTS OF THE CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX-ACTIVITY (CLASI-A) ARE RELEVANT TO IDENTIFY AND DETECT CHANGES IN SKIN ACTIVITY	9
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment	9
Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases	9
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series	9
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment	8
TYPE 2 LUPUS IS THE MAJOR PREDICTOR OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL STUDY OF 200 PATIENTS	8
Elevated Serum Brain Injury Markers Correlate with Disease Features and Interferons in Children with Systemic Lupus Erythematosus	8
IMIQUIMOD-INDUCED ONSET OF DISEASE IN LUPUS-PRONE NZB/W F1 MICE	8
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists	8
CARDIAC LUPUS: A DISEASE NOT TO BE NEGLECTED.	8
BRIDGING THE GAP: IDENTIFYING AND ADDRESSING BARRIERS TO CARE FOR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS	8
Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study	8
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis	8
Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus	8
ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS	8
IMPACT OF BELIMUMAB ON EFFICACY, SAFETY AND IMMUNE PHENOTYPES IN REFRACTORY AND ACTIVE LUPUS NEPHRITIS IN REAL-WORLD LOOPS REGISTRY	8
Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry	8
VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE	8
The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis	8
Advances in Psoriatic Disease Research: Insights From GRAPPA Pilot Research Awardees	8
MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPORT OF 8 CASES	8
EXPEDITING LUPUS CLASSIFICATION OF AT-RISK INDIVIDUALS USING NOVEL TECHNOLOGY: OUTCOMES OF A PILOT STUDY	8
DOWNREGULATION OF YTHDF2 IN THE SPINAL DORSAL HORN CONTRIBUTES TO THE GENESIS OF CHRONIC PAIN INDUCED BY SYSTEMIC LUPUS ERYTHEMATOSUS	8
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study	8
Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality	8
Comparing Large Vessel Uptake of 68Ga-HA-DOTATATE to 18F-FDG Using PET/CT Imaging in Patients with Active Giant Cell Arteritis	7
A Clinical Audit of Vaccination in Patients Living with Inflammatory Arthritis and Receiving Specialty Medications	7
An Evaluation of Burnout Among US Rheumatology Fellows: A National Survey	7
The Prognostic Potential of End-Stage Knee Osteoarthritis and Its Components to Predict Knee Replacement: Data From the Osteoarthritis Initiative	7
Infections in Vasculitis: Can We Create an Epidemic of Change?	7
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	7
Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2B/3 Trials	7
The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases	7
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome	7
Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients With Rheumatoid Arthritis	7
Dr. Berti et al reply	7
Patient-Provider Communication in Pediatric Rheumatology: A Narrative Review and Presentation of Pilot Data	7
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study	7
Impaired Neutrophil Extracellular Trap (NET) Degradation in Rheumatoid Arthritis (RA) and Preclinical RA Is Mediated by Anti-NET Antibodies	7
Association Between Depressive Symptoms and Self-Reported Physical Activity in Persons With Knee Osteoarthritis	7
GRAPPA 2024: Innovations in Education Workshop	7
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting	7
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases	7
Utilization of Rehabilitation Services After Idiopathic Inflammatory Myopathy (IIM) Diagnosis: A US Retrospective Cohort Assessment	7
REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NONMEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS	6
DAPIROLIZUMAB PEGOL DEMONSTRATED IMPROVEMENT IN QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: LUPUSQOL RESULTS FROM A PHASE 3 TRIAL	6
Janus Kinase Inhibitor Exposure During Pregnancy in Immune-Mediated Inflammatory Diseases: A Case Series of 3 Patients	6
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response	6
Development of National Clinical Practice Guidelines for Transition in Rheumatology	6
Arthritis Mutilans in Psoriatic Arthritis: The Consequences of Delayed Treatment	6

Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey	6
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study	6
Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study	6
EFFICACY AND SAFETY OF ELSUBRUTINIB AND UPADACITINIB COMBINATION AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS THROUGH 104 WEEKS	6
The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease	6
A SURVEY OF PATIENTS WITH SLE SUGGESTS LIMITED KNOWLEDGE OF NEPHRITIS UNLESS THERE IS ALREADY CHRONIC KIDNEY DISEASE	6
PROPOSALS FOR DEFINITIONS OF MODERATE AND SEVERE DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. IMPACT ON FLARES, QUALITY OF LIFE, DAMAGE ACCRUAL, HOSPITALIZATIONS AND MORTALITY	6
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	6
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?	6
Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study	6
Golimumab for Adherence in Rheumatoid Arthritis (GO FAR): A Multicenter, Prospective, Observational Study of Patients Treated with Golimumab for Rheumatoid Arthritis	6
The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort	6
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis	6
ANIFROLUMAB EFFECTS ON RESPONSE TO INFLUENZA VACCINE IN SLE	6
EFFICACY AND SAFETY OF TACROLIMUS IN THE MAINTENANCE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS	6
DMARD Utilization Patterns in Community-Dwelling Rheumatoid Arthritis Patients: Insights from Linked Primary Care and Pharmaceutical Data	6
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort	6
MPO-ANCA Positivity in a Patient with Pyoderma Gangrenosum and Graves’ Disease: A Case Report and Review of the Literature	6
A Frameshift Mutation ofNLRP12in a Patient With Chronic Recurrent Multifocal Osteomyelitis	6
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study	6
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events	6
Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study	6
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS	6
The Use of Real-World Data for Studies of Dynamic Disease Processes	5
Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients With Active Rheumatoid Arthritis	5
Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study	5
Sociocultural and Economic Disparities in Physical Therapy Utilization Among Insured Older Adults With Rheumatoid Arthritis	5
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe	5
The Road to a New Horizon in Psoriatic Arthritis	5
Rapid Review of Transition Outcomes in Youth with Rheumatic Diseases	5
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis	5
NONINVASIVE HIGH-THROUGHPUT SERUM PROTEOMICS FOR DISTINGUISHING SUBTYPES OF LUPUS NEPHRITIS	5
Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody–Positive Dermatomyositis: An Observational Survey	5
ANTI-C1Q ANTIBODIES AS INDICATORS OF DISEASE ACTIVITY, RENAL INVOLVEMENT, AND NON-SCARRING ALOPECIA IN PATIENTS WITH SLE	5
Metabolic Stress Remodeling: Insights into the Role(s) of FOXO1 in Promoting Cancer-Like Changes in Systemic Sclerosis (SSc)	5
NOVEL 3-BASE OLIGONUCLEOTIDE THERAPEUTIC SOF-SKN™ ANTAGONISES TLR7/8 IN AUTOIMMUNE SKIN DISEASE	5
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network	5
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES – THE LUPUSNET FEDERATED DATA NETWORK	5
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis	5
Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry	5
Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis	5
Sarcopenia as a Feature of Musculoskeletal Manifestations of Pediatric Crohn’s Disease	5
How Representative Are Data From Clinical Trials in Axial Spondyloarthritis for Women?	5
Seronegative Sjögren Syndrome: A Forgotten Entity?	5
Dose-Response Relationship Between Alcohol Consumption and Gout Risk: Do Subtypes of Alcoholic Beverages Make a Difference?	5
Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex	5
Emergency Department Visits for Ambulatory Care Sensitive Conditions by Persons with Rheumatoid Arthritis: A Population-Based Study	5
Autoinflammatory Diseases and Vasculitis: The Missing Link	5
REDUCED FREQUENCY OF CIRCULATING INTERLEUKIN-16 EXPRESSING CD4+AND CD8+T CELLS ASSOCIATE WITH INCREASED URINARY IL16 LEVELS AND PROMOTE TH1 AND CD8+T CELL MIGRATION IN LUPUS PATIENTS	5
Optimizing Care for Pregnancy in Rheumatic Diseases: Barriers and Potential Solutions	5
DEVELOPMENT OF A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FOR THERAPEUTIC EVALUATION IN A VIRTUAL POPULATION	5
Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept	5
AUTOIMMUNE DISEASE PREVALENCE IN PEOPLE LIVING WITH HIV AT CIPTO MANGUNKUSUMO GENERAL HOSPITAL: A COHORT STUDY	5
Elucidating the Program Theory of a Successful Interdisciplinary Team-Based Model of Rheumatology Care: An Implementation Science Exploratory Case Study	5
EXPLORING PHYSICAL ACTIVITY ENGAGEMENT AND SUPPORT IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE IMPACT OF SOCIAL SUPPORT, HEALTHCARE PROVIDER RELATIONSHIPS, AND BUILT ENVIRONMENTS	5
Co-Designing a Patient-Facing Dashboard with Patients and Healthcare Providers: Gathering User Input	5
50 Years ofThe Journal of Rheumatology	5
Patient Perspectives and Experiences With Medication for Gout: A Thematic Synthesis of Qualitative Studies	5
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group	5
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	5
DisseminatedMycobacterium haemophilumInfection Mimicking Rheumatoid Nodules	5
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk	5
Degenerative Disc Disease in Young Adults With Psoriatic Arthritis	5
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus	5
Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment	5
Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin D: Results from the PASCOD Study, an RA Prevention Protocol	5
A EULAR/ACR (2019) SLE CLASSIFICATION CRITERIA SCORE ≥20 IS A MARKER OF SEVERE DISEASE IN A PREVALENT SLE COHORT FROM THE PORTUGUESE REUMA.PT REGISTRY	5
Analyzing Gender Disparities in Ankylosing Spondylitis: Exploring the Factors Behind Severe Sacroiliac Joint Disease Without Spinal Involvement	5
REAL-WORLD ASSESSMENT OF PATTERNS OF PAIN TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: A PATHWAY VISUALIZATION STUDY USING EHR	5
Immune Checkpoint Inhibitors: A Pediatric Needs Assessment	5
RESPONSE TO HYDROXYCHLOROQUINE IN IMMUNE THROMBOCYTOPENIA IN CHILDHOOD-ONSET SLE	5
Bimekizumab Maintained Stringent Clinical Responses Over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies	5
ANALYSIS OF PULMONARY COMPLICATIONS IN SLE PATIENTS WITH AND WITHOUT COVID-19: A NATIONAL INPATIENT STUDY	5
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls	5
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024	5
Getting the Diagnosis Right: What’s in a Name?	5
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies	5
SAFETY OF FERTILITY TREATMENTS IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A FRENCH PROSPECTIVE POPULATION-BASED STUDY	4
LUPUS RESEARCH ALLIANCE 2024-2028 RESEARCH STRATEGIC PLAN: ACCELERATING PRECISION MEDICINE FOR PEOPLE LIVING WITH LUPUS	4
Dual-Energy Computed Tomography Has Additional Prognostic Value Over Clinical Measures in Gout Including Tophi: A Systematic Literature Review	4
Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody–Positive Myositis: A Retrospective Cohort Study in China	4
SAFETY PROFILE OF VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM PROSPECTIVE MULTICENTRIC STUDY - SAFER STUDY	4
INTRA-RENAL INVOLVEMENT IN PRIMARY ANTIPHOSPHOLIPID ANTIBODIES SYNDROME: DATA FROM 2 ITALIAN CENTERS	4
COMPARATIVE ANALYSIS OF BELIMUMAB, ANIFROLUMAB, AND RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A RETROSPECTIVE STUDY OF CLINICAL AND ANALYTICAL OUTCOMES	4
CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: PREGNANCY AND BIRTH OUTCOMES IN ONTARIO	4
RENAL BIOPSY DATA IN LUPUS PATIENTS WITH LOW PROTEINURIA	4
NUCLEOLAR DISRUPTION IN AUTOIMMUNE AND NEURODEGENERATIVE DISEASES	4
A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF CB-010, A NEXT-GENERATION CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY, IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (GALLOP)	4
MRL-LPR MICE DISPLAY ALTERED NOCICEPTION: A POSSIBLE MODEL FOR LUPUS PERIPHERAL NEUROPATHY	4
Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment	4
Effective Treatment of Janus Kinase 1/3 Inhibitor in Blau Syndrome From a Multicenter Retrospective Study in Central China	4
FINE PARTICULATE MATTER AIR POLLUTION AND ANTINUCLEAR ANTIBODY POSITIVITY: THE ONTARIO HEALTH STUDY	4
SYSTEMIC LUPUS ERYTHEMATOSUS PREGNANCIES: TRENDS IN DISEASE MANAGEMENT AND MATERNAL – FETAL OUTCOMES COMPARING 2 TIME PERIODS (1988-2012 VS 2013-2022)	4
LONG-TERM OUTCOMES OF PATIENTS WITH PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (PSLE) TREATED WITH COMBINATION RITUXIMAB AND CYCLOPHOSPHAMIDE: A SINGLE-CENTER COHORT AND REVIEW OF LITERATURE	4
COMPLEMENTARY LUPUS-SPECIFIC INDEXES INFORMED BY SELECT IMMUNE MEDIATORS CHARACTERIZE RISK OF CONCURRENT DISEASE ACTIVITY AND FUTURE IMPENDING FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS	4